Hypersomnia Foundation

OUR MISSION

The Hypersomnia Foundation strives to improve the lives of people with hypersomnia by advocating on their behalf, providing support, educating the public and healthcare professionals, raising awareness, and funding research into effective treatments, better diagnostic tools, and, ultimately, a cure for these debilitating conditions.

OUR CORE BELIEFS

OUR GOALS & OBJECTIVES

  1. To increase community and physician awareness of the primary Hypersomnia syndromes.
  2. To provide a source of high quality, timely education for both people with Hypersomnia and health care providers regarding Hypersomnia.
  3. To form a community of people with Hypersomnia and their loved ones for mutual support.
  4. To promote much needed research into the causes and treatments of Hypersomnia, with a special focus on novel ideas with excellent potential for transforming care of people with Hypersomnia
.
  5. To assist in translating new discoveries into improved outcomes and quality of life for people with Hypersomnia.

FOUNDING BOARD MEMBERS

 

 

SCIENTIFIC ADVISORY BOARD

Andrew Jenkins, PhD. Dr Jenkins is an Associate Professor of Anesthesiology at and Assistant Professor of Pharmacology at Emory University who studies drugs and chemicals that induce sleep, and inhibit brain function. He has identified several new drug-binding sites in the brain and is currently investigating how inhibitory ion-channels control the function of brain cells. Andrew received his doctorate in Biophysics from Imperial College, London.

David Rye, MD., PhD.  Dr. Rye is a Professor of Neurology at Emory University and specializes in hypersomnia, narcolepsy, restless leg syndrome and other sleep disorders. He graduated from University of Chicago School of Medicine. He and his team discovered the trypsin-sensitive substance in the brain that stimulates GABA receptors and induces sleep.

MEDICAL ADVISORY BOARD

Lynn Marie Trotti, MD, MSc. Dr. Trotti is an Assistant Professor of Neurology at Emory University who specializes in idiopathic hypersomnia, narcolepsy, and other sleep disorders.  She has recently completed two clinical trials of novel medications for hypersomnia, and continues to investigate causes underlying excessive sleepiness and related symptoms.